Welcome to our dedicated page for CEA Industries SEC filings (Ticker: BNCWW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on CEA Industries's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into CEA Industries's regulatory disclosures and financial reporting.
CEA Industries Inc. announced that its Board has proposed amendments to the Asset Management Agreement with 10X Capital Asset Management LLC. The Board is seeking lower management fees, a shorter term and a more favorable termination provision to make the structure more cost-efficient.
10X has indicated it is willing to work cooperatively on potential changes, and the Board aims to conclude discussions quickly. The move follows the public confirmation by YZi Labs that it terminated a side agreement with 10X that had limited 10X’s ability to amend the arrangement. The company also plans to file a consent revocation statement in response to YZi Labs’ consent solicitation.
YZi Labs Management Ltd. and a group of participants have launched a written consent campaign seeking to expand the Board of Directors of CEA Industries Inc. and elect their own nominees. They have filed a preliminary consent statement and will use a WHITE consent card to solicit stockholders.
YZi Labs Management directly beneficially owns 2,150,481 shares of CEA Industries common stock. It also holds warrants exercisable into 7,750,510 shares under Pre-Funded Warrants, 9,900,991 shares under Stapled Warrants and 3,564,359 shares under Strategic Advisor Warrants, all subject to a 4.99% beneficial ownership limitation. Ms. Jiajin He may be deemed to beneficially own 2,099,644 shares of common stock, including 1,188,120 shares underlying Stapled Warrants, and Mr. Alex Odagiu may be deemed to beneficially own 4,918 shares, while the other named participants currently report no beneficial ownership.
YZi Labs Management Ltd. and associated participants have launched a consent solicitation aimed at changing the leadership of CEA Industries Inc.. They have filed a preliminary consent statement and are using a WHITE consent card to seek stockholder written consents to expand the Board of Directors and elect their own nominees.
YZi Labs Management directly beneficially owns 2,150,481 shares of CEA common stock and holds additional Pre-Funded, Stapled and Strategic Advisor Warrants subject to a 4.99% Beneficial Ownership Limitation, which currently prevents exercise for at least 60 days. Other participants include Changpeng Zhao, who may be deemed to beneficially own YZi Labs Management’s common shares, and Jiajin He and Alex Odagiu, who are disclosed as beneficial owners of specified common stock amounts and warrants.
YZi Labs Management Ltd. has launched a consent solicitation seeking written approvals from CEA Industries Inc. stockholders to expand the Board of Directors and elect its nominated candidates. This effort is supported by several participants, including Changpeng Zhao, Max Baucus Sieben and others.
YZi Labs Management directly beneficially owns 2,150,481 shares of CEA Industries common stock. It also holds warrants currently linked to 7,750,510 pre-funded shares, 9,900,991 stapled warrant shares and 3,564,359 strategic advisor warrant shares, all subject to a 4.99% beneficial ownership limitation that makes these warrants non-exercisable at this time.
YZi Labs Management Ltd. and affiliated participants have begun a consent solicitation to expand the Board of Directors of CEA Industries Inc. and elect their nominated directors. YZi Labs Management directly beneficially owns 2,150,481 shares of common stock. It also holds warrants for an additional 21,215,860 shares of common stock that are currently not exercisable, and not expected to become exercisable within 60 days, due to 4.99% beneficial ownership limits. Other participants, including Changpeng Zhao and several proposed directors, are identified with their respective current or zero beneficial ownership positions.
CEA Industries Inc. filed a Form 8-K to report that on September 22, 2025 it issued a press release announcing its financial and operational results for the first quarter ended July 31, 2025. The press release containing these results is furnished as Exhibit 99.1 to the report. The company’s common stock and warrants trade on the Nasdaq Capital Market under the symbols BNC and BNCWW, respectively.
CEA Industries Inc. (BNCWW) reported interim consolidated results and disclosures related to the June–July 2025 Successor period following multiple acquisitions. The company had approximately $3.0 million of cash and a working capital deficit of about $1.0 million as of July 31, 2025 (Successor). Management discloses a PIPE/private placement commitment and offering expected to provide substantial liquidity: a private placement closed August 5, 2025 that delivered $500 million in gross proceeds with up to $750 million additional proceeds possible from warrant exercises.
The company acquired the Fat Panda group, allocating purchase consideration of approximately $12.8 million (about $10.6 million cash, 39,000 shares valued ~$0.3 million and seller notes totaling $1.9 million), recording $4.22 million of goodwill and significant identifiable intangibles. Operating results for the period show a material operating loss of $(5.6) million and loss before tax of $(5.9) million. The company drew a $4.0 million bridge loan (due December 3, 2025) and reports related-party notes and convertible notes with various terms. Deposit concentrations include approximately CAD $3.51 million and $153,000 in cash deposits in excess of CDIC and FDIC insurance limits, respectively.
CEA Industries Inc. filed a current report to let investors know it has shared a new letter with its shareholders. The letter, dated September 21, 2025, explains that the company filed a registration statement on September 19, 2025 to register securities issued in a recently completed PIPE transaction and a related warrant transaction, and it also provides an update on the company’s operations. The shareholder letter is included as Exhibit 99.1 to this report, but the company specifies that this information is being furnished under Regulation FD and is not treated as filed for liability purposes under the securities laws.
CEA Industries, Inc. (BNCWW) filed an S-3ASR prospectus registration that lists the securities being registered for resale by numerous selling stockholders and describes the offering mechanics and estimated expenses. The prospectus excerpt names over a hundred institutional and individual selling stockholders with specific share quantities each intends to offer, including material positions such as YZi Labs Management Ltd. holding 23,366,341 shares as of September 19, 2025. The filing also discloses aggregate instruments tied to the offering: 2,150,481 shares of Common Stock, 7,750,510 shares underlying Pre-Funded Warrants, 9,900,991 shares underlying Stapled Warrants and 3,564,359 shares underlying Strategic Advisor Warrants (assumptions include full exercise and sale of the referenced warrants).
The document includes a prospectus table of contents, use-of-proceeds categories (working capital, capital expenditures, share repurchases, debt repayment, and pursuit of a BNB treasury strategy), a schedule of estimated offering expenses, and standard selling-stockholder beneficial ownership and control disclaimers tied to each named holder.